222 related articles for article (PubMed ID: 8238915)
1. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
2. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
Lamarche N; Gaudreau P; Massie B; Langelier Y
Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
[TBL] [Abstract][Full Text] [Related]
3. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.
Sun Y; Conner J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):97-104. PubMed ID: 10727407
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.
Cohen EA; Gaudreau P; Brazeau P; Langelier Y
Nature; 1986 May 22-28; 321(6068):441-3. PubMed ID: 3012360
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.
Gaudreau P; Michaud J; Cohen EA; Langelier Y; Brazeau P
J Biol Chem; 1987 Sep; 262(26):12413-6. PubMed ID: 3040743
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.
Paradis H; Gaudreau P; Brazeau P; Langelier Y
J Biol Chem; 1988 Nov; 263(31):16045-50. PubMed ID: 2846533
[TBL] [Abstract][Full Text] [Related]
7. Oligopeptide inhibition of class I ribonucleotide reductases.
Cooperman BS
Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
[TBL] [Abstract][Full Text] [Related]
8. Identification of structural domains within the large subunit of herpes simplex virus ribonucleotide reductase.
Conner J; Cross A; Murray J; Marsden H
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3327-35. PubMed ID: 7996127
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
[TBL] [Abstract][Full Text] [Related]
10. Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.
McClements W; Yamanaka G; Garsky V; Perry H; Bacchetti S; Colonno R; Stein RB
Virology; 1988 Jan; 162(1):270-3. PubMed ID: 2827385
[TBL] [Abstract][Full Text] [Related]
11. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and inhibitory potency of peptides corresponding to the subunit 2 C-terminal region of herpes virus ribonucleotide reductases.
Gaudreau P; Paradis H; Langelier Y; Brazeau P
J Med Chem; 1990 Feb; 33(2):723-30. PubMed ID: 2153825
[TBL] [Abstract][Full Text] [Related]
13. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.
Peng T; Hunter JR; Nelson JW
Virology; 1996 Feb; 216(1):184-96. PubMed ID: 8614985
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of active subunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhibiting a protein kinase activity.
Paradis H; Gaudreau P; Massie B; Lamarche N; Guilbault C; Gravel S; Langelier Y
J Biol Chem; 1991 May; 266(15):9647-51. PubMed ID: 1851753
[TBL] [Abstract][Full Text] [Related]
15. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells.
Conner J; Murray J; Cross A; Clements JB; Marsden HS
Virology; 1995 Nov; 213(2):615-23. PubMed ID: 7491785
[TBL] [Abstract][Full Text] [Related]
17. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I.
Gaudreau P; Brazeau P; Richer M; Cormier J; Langlois D; Langelier Y
J Med Chem; 1992 Jan; 35(2):346-50. PubMed ID: 1310120
[TBL] [Abstract][Full Text] [Related]
19. Studies on in vitro proteolytic sensitivity of peptides inhibiting herpes simplex virus ribonucleotide reductases lead to discovery of a stable and potent inhibitor.
Paradis H; Langelier Y; Michaud J; Brazeau P; Gaudreau P
Int J Pept Protein Res; 1991 Jan; 37(1):72-9. PubMed ID: 1646184
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL.
Telford E; Lankinen H; Marsden H
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1373-8. PubMed ID: 2161904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
